enow.com Web Search

  1. Ads

    related to: treatments for macular degeneration

Search results

  1. Results from the WOW.Com Content Network
  2. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]

  3. Stem cell therapy for macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Stem_cell_therapy_for...

    Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

  4. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    Macular degeneration treatment is safe and effective. The FDA approval was based on a review of scientific evidence showing that both drugs are “highly similar” to Regeneron Pharmaceuticals’ ...

  5. Gene therapy of the human retina - Wikipedia

    en.wikipedia.org/wiki/Gene_therapy_of_the_human...

    Following the successful clinical trials in LCA, researchers have been developing similar treatments using adeno-associated virus for age-related macular degeneration (AMD). To date, efforts have focused on long-term delivery of VEGF inhibitors to treat the wet form of macular degeneration. Whereas wet AMD is currently treated using frequent ...

  6. Anti-VEGF - Wikipedia

    en.wikipedia.org/wiki/Anti-VEGF

    In 2008, this study, called the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT Study), enrolled about 1,200 patients with newly diagnosed wet AMD. The patients were assigned randomly to different treatment groups, and the data was collected from 2008 to 2009.

  7. Intravitreal gene therapy - Wikipedia

    en.wikipedia.org/wiki/Intravitreal_gene_therapy

    Once inside, the therapeutic genes are expressed to address genetic deficiencies or modify biological pathways, offering a long-term or potentially permanent treatment ("biofactory approach") for conditions like wet age-related macular degeneration (AMD), diabetic macular edema, and inherited retinal dystrophies. [2]

  1. Ads

    related to: treatments for macular degeneration